Clair McClung, MD
Clair McClung, MD
Fellow
H. Lee Moffitt Cancer Center & Research Institute
12902 Magnolia Dr
Tampa,
FL
USA
33612
Papers:
181
Molecular signaling pathways associated with squamous-cell carcinoma of the cervix cisplatin-resistance
286
Unique molecular portraits of ovarian cancer: implications for prognostics and targeted therapeutics
340
AKT survival signaling and phospho-AKT expression are associated with triple negative breast cancer development and clinical outcome
437
AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome
515
Repurposing Artesunate, an anti-malarial, for ovarian cancer treatment: mechanistic insights from cell line models